Arm's Chip Game Changer: Is It Time to Buy ARM Stock Now
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
Reinforcing budgeting discipline involves regular reviews, automated savings, and mindful spending. Build confidence by sticking to small, repeatable actions.
17,282 articlesArm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Disney's stock is under renewed pressure as its core businesses face slower growth. The market is awaiting clearer pr...
U.S. consumer discretionary stocks rise as demand improves in March 2026. Analysts cite pricing power and resilient c...
As AI investment expands across big-cap tech and startups, ACM Research and Ouster emerge as practical additions to s...
Core Scientific reports higher first-quarter revenue and gross profit, yet a net loss due to impairment charges derai...
The market has sprinted higher, and valuations feel stretched. History, however, shows that corrections are a normal ...
Barclays slashed Coinbase’s price target to $107 following aQ1 2026 revenue miss, highlighting a tug-of-war between c...
Income investors are eyeing a familiar Dividend King delivering a near-3% yield. This article breaks down what that s...
Upstart stock has taken a hard one-way trip downward, leaving some investors wondering if a rebound is possible. This...
UBS downgraded Dell Technologies to Neutral after a blistering 157% rally, raising the target to $243 and signaling v...
This article breaks down Rekor’s Q1 2026 earnings call in plain English. Learn what the numbers mean for the rekor (r...